Yazji Salim 4
4 · Oncternal Therapeutics, Inc. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Yazji Salim
Chief Medical Officer
Transactions
- Award
Common Stock
2022-07-28+82,500→ 149,637 total - Award
Stock Option
2022-07-28+55,000→ 55,000 totalExercise: $1.04Exp: 2032-07-28→ Common Stock (55,000 underlying)
Footnotes (2)
- [F1]Represents an award of restricted stock units (RSUs). Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. One half of the RSUs vest on July 3, 2023, and one half of the RSUs vest on January 3, 2024, subject to the Reporting Person's continued employment or service with the Issuer on each such date. All of the RSUs vest in the event of a Change in Control (as defined in the Issuer's 2019 Incentive Award Plan).
- [F2]One half of the shares subject to the stock options vest on July 3, 2023 and one half of the shares subject to the stock options vest on January 3, 2024, subject to the Reporting Person's continued employment or service with the Issuer on each such date. All of the shares subject to the stock options vest in the event of a Change in Control (as defined in the Issuer's 2019 Incentive Award Plan).